Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP252204.RApk-gatijT6ksxJIptJKv9XAIoW9oPlYwrSErVQEv58g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP252204.RApk-gatijT6ksxJIptJKv9XAIoW9oPlYwrSErVQEv58g130_assertion type Assertion NP252204.RApk-gatijT6ksxJIptJKv9XAIoW9oPlYwrSErVQEv58g130_head.
- NP252204.RApk-gatijT6ksxJIptJKv9XAIoW9oPlYwrSErVQEv58g130_assertion wasGeneratedBy ECO_0000203 NP252204.RApk-gatijT6ksxJIptJKv9XAIoW9oPlYwrSErVQEv58g130_provenance.
- NP252204.RApk-gatijT6ksxJIptJKv9XAIoW9oPlYwrSErVQEv58g130_assertion wasDerivedFrom befree-2016 NP252204.RApk-gatijT6ksxJIptJKv9XAIoW9oPlYwrSErVQEv58g130_provenance.
- NP252204.RApk-gatijT6ksxJIptJKv9XAIoW9oPlYwrSErVQEv58g130_assertion SIO_000772 10318905 NP252204.RApk-gatijT6ksxJIptJKv9XAIoW9oPlYwrSErVQEv58g130_provenance.
- NP252204.RApk-gatijT6ksxJIptJKv9XAIoW9oPlYwrSErVQEv58g130_assertion evidence source_evidence_literature NP252204.RApk-gatijT6ksxJIptJKv9XAIoW9oPlYwrSErVQEv58g130_provenance.
- NP252204.RApk-gatijT6ksxJIptJKv9XAIoW9oPlYwrSErVQEv58g130_assertion description "[Using AG879, a HER2/Neu inhibitor, and PD98059, a MAP kinase inhibitor, as well as MAP kinase phosphatase-1 (MPK-1), in the transfection assay, we found that HER2/Neu could induce prostate-specific antigen (PSA), a marker for the progression of prostate cancer, through the MAP kinase pathway at a low androgen level.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP252204.RApk-gatijT6ksxJIptJKv9XAIoW9oPlYwrSErVQEv58g130_provenance.